Scientists at the NIH's National Eye Institute have developed a promising gene therapy strategy for a form of Leber congenital amaurosis (ACL), a rare disease that causes severe vision loss in children. The scientists tested their approach using retinal tissue made in the lab from patient cells, called retinal organoids, one of which is pictured here.